HomeClinical TopicsCardio-PulmonaryFDA approves Omontys for anemia in dialysis patients

FDA approves Omontys for anemia in dialysis patients

On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease and are on dialysis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

menopause and sleep problems

Menopause and Sleep Problems

Data shows that sleep disturbances increase in prevalence during the menopausal transition, with the most common complaint being nighttime awakenings. Take our quick three-question survey...